ZA925322B - Antihypertensive combination - Google Patents

Antihypertensive combination

Info

Publication number
ZA925322B
ZA925322B ZA925322A ZA925322A ZA925322B ZA 925322 B ZA925322 B ZA 925322B ZA 925322 A ZA925322 A ZA 925322A ZA 925322 A ZA925322 A ZA 925322A ZA 925322 B ZA925322 B ZA 925322B
Authority
ZA
South Africa
Prior art keywords
atoms
phenyl
alkyl
radical
halogen
Prior art date
Application number
ZA925322A
Other languages
English (en)
Inventor
Jean-Paul Clozel
Clozel Jean-Paul
Rita Muller
Muller Rita
Wolfgang Osterrieder
Osterrieder Wolfgang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA925322B publication Critical patent/ZA925322B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
ZA925322A 1991-07-23 1992-07-16 Antihypertensive combination ZA925322B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH219191 1991-07-23

Publications (1)

Publication Number Publication Date
ZA925322B true ZA925322B (en) 1993-03-31

Family

ID=4228024

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925322A ZA925322B (en) 1991-07-23 1992-07-16 Antihypertensive combination

Country Status (31)

Country Link
US (1) US5620975A (lv)
EP (1) EP0524512B1 (lv)
JP (1) JPH0680009B2 (lv)
KR (1) KR100260479B1 (lv)
CN (1) CN1040505C (lv)
AT (1) ATE260661T1 (lv)
AU (1) AU656207B2 (lv)
BG (1) BG60949B1 (lv)
BR (1) BR9202830A (lv)
CA (1) CA2074039C (lv)
CZ (1) CZ281691B6 (lv)
DE (1) DE59209993D1 (lv)
DK (1) DK0524512T3 (lv)
ES (1) ES2215160T3 (lv)
HR (1) HRP930953B1 (lv)
HU (1) HU214029B (lv)
IE (1) IE922378A1 (lv)
IL (1) IL102541A (lv)
IS (1) IS3887A (lv)
MX (1) MX9204212A (lv)
MY (1) MY118064A (lv)
NO (1) NO301047B1 (lv)
NZ (1) NZ243577A (lv)
PT (1) PT524512E (lv)
RO (1) RO110905B (lv)
RU (1) RU2084225C1 (lv)
SK (1) SK278918B6 (lv)
TW (1) TW216770B (lv)
UY (1) UY23449A1 (lv)
YU (2) YU72392A (lv)
ZA (1) ZA925322B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409631D1 (de) * 1993-07-15 2001-02-15 Hoffmann La Roche Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
IL131816A (en) 1997-04-04 2003-06-24 Exxon Res & Engineering Compan Composite structures having high containment strength
US6608097B2 (en) 2001-10-10 2003-08-19 Aryx Therapeutics Materials and methods for the treatment of hypertension and angina
US7687086B1 (en) 2003-02-28 2010-03-30 University Of Portland Method for obtaining taxanes
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
KR940005408B1 (ko) * 1990-12-03 1994-06-18 만도기계 주식회사 파워 윈도우 모우터 회전자의 선단부 흔들림 측정장치

Also Published As

Publication number Publication date
TW216770B (lv) 1993-12-01
RO110905B (ro) 1996-05-30
BG60949B1 (bg) 1996-07-31
SK227092A3 (en) 1996-02-07
HRP930953A2 (en) 1995-10-31
IE922378A1 (en) 1993-01-27
BG96664A (bg) 1993-12-24
KR100260479B1 (ko) 2000-07-01
IL102541A (en) 1995-12-08
NO922903L (no) 1993-01-25
IS3887A (is) 1993-01-24
YU49198B (sh) 2004-09-03
MY118064A (en) 2004-08-30
CA2074039A1 (en) 1993-01-24
YU72392A (sh) 1997-05-28
CN1068737A (zh) 1993-02-10
NZ243577A (en) 1994-09-27
JPH0680009B2 (ja) 1994-10-12
AU656207B2 (en) 1995-01-27
HUT62792A (en) 1993-06-28
CA2074039C (en) 2004-11-02
NO922903D0 (no) 1992-07-22
HU9202367D0 (en) 1992-10-28
CN1040505C (zh) 1998-11-04
HU214029B (en) 1997-12-29
NO301047B1 (no) 1997-09-08
ATE260661T1 (de) 2004-03-15
MX9204212A (es) 1993-08-01
CZ281691B6 (cs) 1996-12-11
BR9202830A (pt) 1993-03-23
SK278918B6 (sk) 1998-04-08
EP0524512B1 (de) 2004-03-03
UY23449A1 (es) 1993-01-21
JPH05194217A (ja) 1993-08-03
US5620975A (en) 1997-04-15
HRP930953B1 (en) 2003-06-30
AU2041692A (en) 1993-01-28
IL102541A0 (en) 1993-01-14
EP0524512A2 (de) 1993-01-27
DE59209993D1 (de) 2004-04-08
ES2215160T3 (es) 2004-10-01
RU2084225C1 (ru) 1997-07-20
PT524512E (pt) 2004-07-30
DK0524512T3 (da) 2004-07-05
CZ227092A3 (en) 1993-02-17
EP0524512A3 (en) 1993-09-01
KR930001910A (ko) 1993-02-22

Similar Documents

Publication Publication Date Title
MY111190A (en) Substituted thiazolidinedione derivatives
ES2081120T3 (es) Procedimiento para la preparacion de derivados de la bacatina iii y la desacetil-10 bacatina iii.
GB9308487D0 (en) Novel compounds
FI881950A0 (fi) Hyönteisten ja punkkien karkoitteet
TW216770B (lv)
IL89156A0 (en) Derivatives of 2-((4-piperidinyl)methyl)-1,2,3,4,-tetrahydroisoquinoline,their preparation and their application in therapeutics
TW230771B (lv)
SE8800863D0 (sv) 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith
MX9633A (es) Procedimiento para la preparacion de nuevos productos esteroides que llevan en la posicion 23 un radical sulfinilo y producto obtenido.
ES8607265A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes
NZ221004A (en) 2,6-piperazinediones and pharamceutical compositions
ATE105565T1 (de) Pradimicinderivate.
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ZA80742B (en) Thiazole derivatives and their use in therapy
ZA894399B (en) New derivatives of phenothiazine,their preparation and the compositions which contain them
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
ES2053919T3 (es) Derivados del indano.
DK89685A (da) Allopurinolderivater
ES8602825A1 (es) Un procedimiento para preparar un compuesto fosforoditioico